GetTopicDetailResponse(id=6bea122683b5, topicName=肝轉(zhuǎn)移胃腸道癌, introduction=, content=化療 安羅替尼 肝轉(zhuǎn)移胃腸道癌, image=null, comments=0, allHits=478, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Dec 22 17:17:49 CST 2024, time=2024-12-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=499574, tagList=[TagDto(tagId=499574, tagName=肝轉(zhuǎn)移胃腸道癌)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2244355, encodeId=058222443559d, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化療#</a> <a href='/topic/show?id=a20e45830e0' target=_blank style='color:#2F92EE;'>#安羅替尼#</a> <a href='/topic/show?id=6bea122683b5' target=_blank style='color:#2F92EE;'>#肝轉(zhuǎn)移胃腸道癌#</a>, objectTitle=STTT | 安羅替尼聯(lián)合化療作為不可切除肝轉(zhuǎn)移胃腸道癌癥患者的一線治療方案：一項多隊列、多中心、探索性試驗, objectType=article, longId=855939, objectId=b39f85593970, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719541210140_92910.jpg, objectUrl=/article/show_article.do?id=b39f85593970, replyNumber=0, likeNumber=56, createdTime=2024-12-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=b39f85593970, moduleTitle=STTT | 安羅替尼聯(lián)合化療作為不可切除肝轉(zhuǎn)移胃腸道癌癥患者的一線治療方案：一項多隊列、多中心、探索性試驗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b39f85593970)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-12-22發(fā)表于陜西省
